These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12095033)

  • 1. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response.
    Sebille F; Guillet M; Brouard S; Gagne K; Petzold T; Blancho G; Vanhove B; Soulillou JP
    Am J Transplant; 2001 May; 1(1):21-8. PubMed ID: 12095033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific.
    Chong AS; Ma LL; Yin D; Blinder L; Shen J; Williams JW
    Xenotransplantation; 2000 Feb; 7(1):48-57. PubMed ID: 10809057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
    Miyatake T; Sato K; Takigami K; Koyamada N; Hancock WW; Bazin H; Latinne D; Bach FH; Soares MP
    J Immunol; 1998 Apr; 160(8):4114-23. PubMed ID: 9558123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C; Coulon F; Haspot F; Mérieau E; Renaudin K; Martinet B; Vanhove B
    Xenotransplantation; 2007 Jan; 14(1):25-33. PubMed ID: 17214702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of cardiac xenografts by CD4+ or CD8+ T cells.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Anrather J; Bach FH
    J Immunol; 1999 Jan; 162(2):1206-14. PubMed ID: 9916754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
    J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of induced xenoantigen expression prevents rejection after retransplantation of accommodated hamster-to-rat heart xenografts.
    Lin Y; Ji P; Xia G; Vandeputte M; Waer M
    Transplantation; 1998 Feb; 65(3):340-5. PubMed ID: 9484749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD4 monoclonal antibody treatment combined with total lymphoid irradiation and cyclosporin A in hamster-to-rat cardiac transplantation. Analysis of lymphocyte subsets and anti-donor xenoantibodies.
    Steinbrüchel DA; Madsen HH; Lillevang S; Nielsen B; Kemp E
    Transpl Immunol; 1993; 1(3):209-16. PubMed ID: 7915954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
    [No Abstract]   [Full Text] [Related]  

  • 11. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.
    Lorant T; Krook H; Wilton J; Olausson M; Tufveson G; Korsgren O; Johnsson C
    Xenotransplantation; 2003 Jul; 10(4):311-24. PubMed ID: 12795680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats.
    Lin Y; Vandeputte M; Waer M
    Transplantation; 1998 Feb; 65(3):332-9. PubMed ID: 9484748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 15. Hamster cardiac xenografts are protected against antibody mediated damage, early after transplantation to Lewis rats.
    Vriens PW; Pollard JD; Hoyt G; Morris RE; Scheringa M; Bouwman E; Robbins RC
    Xenotransplantation; 2001 Nov; 8(4):239-46. PubMed ID: 11737849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rejection of hamster-to-rat heart xenografts.
    Hasan R; van den Bogaerde J; Forty J; Wright L; Wallwork J; White DJ
    Transpl Int; 1992; 5 Suppl 1():S313-7. PubMed ID: 14621810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage depletion prevents anti-graft antibody production and results in long-term survival in xenotransplantation.
    Koyamada N; Sato A; Takayama J; Usuda M; Kawagishi N; Doi H; Fujimori K; Satomi S
    Transplant Proc; 2005; 37(1):514-5. PubMed ID: 15808694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of hamster hearts in presensitized rats.
    Lin Y; Soares MP; Sato K; Csizmadia E; Robson SC; Smith N; Bach FH
    J Immunol; 2000 May; 164(9):4883-92. PubMed ID: 10779798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts.
    Chong AS; Ma LL; Shen J; Blinder L; Yin DP; Williams JW
    Transplantation; 1997 Dec; 64(12):1650-7. PubMed ID: 9422397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells.
    Chen W; Zhou D; Torrealba JR; Waddell TK; Grant D; Zhang L
    J Immunol; 2005 Sep; 175(5):3409-16. PubMed ID: 16116235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.